A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness
Journal of the American Society for Mass Spectrometry · 05.04.2023 · 34 (4) · 754-762
DOI: 10.1021/jasms.3c00022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, online erschienen am 28.03.2023. Verfasst von Jongmin Woo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina …. Hauptthemen laut MEDLINE: Proteomics, Proteome. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Mass spectrometry-based clinical proteomics requires high throughput, reproducibility, robustness, and comprehensive coverage to serve the needs of clinical diagnosis, prognosis, and personalized medicine. Oftentimes these requirements are contradictory to each other. We report the development of a streamlined High-Throughput Plasma Proteomics (sHTPP) platform for untargeted profiling of the blood plasma proteome, which includes 96-well plates and simplified procedures for sample preparation, disposable trap column for peptide loading, robust liquid chromatographic system for separation, data-independent acquisition in tandem mass spectrometry, and DIA-NN, FragPipe, and in-house peptide spectral library-based data analysis. Using the optimized platform at a throughput of 60 samples per day, over 600 protein groups including 57 FDA-approved biomarkers can be consistently identified from whole human plasma, and more than 85% of the detected proteins have 100% completeness in quantitative values across 300 samples. The balance achieved between proteome coverage, throughput, and reproducibility of this sHTPP platform makes it promising in clinical settings, where a large number of samples are to be measured quickly and reliably to support various needs of clinical medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.
- Department of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27402, United States.
ORCID-Profile: Qibin Zhang
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Woo, J., & Zhang, Q. (2023). A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness. Journal of the American Society for Mass Spectrometry, 34(4), 754-762. https://doi.org/10.1021/jasms.3c00022
Vancouver
Woo J, Zhang Q. A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness. Journal of the American Society for Mass Spectrometry. 2023;34(4):754-762. doi:10.1021/jasms.3c00022
BibTeX
@article{Woo2023,
author = {Woo, Jongmin and Zhang, Qibin},
title = {A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2023},
volume = {34},
number = {4},
pages = {754--762},
doi = {10.1021/jasms.3c00022}
}
EUVIMED